Diabetes
Feature
New study of diabetes drug for COVID-19 raises eyebrows
News
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit
Conference Coverage
Excessive sleepiness linked to heart disease, cancer, and diabetes
“Paying attention to sleepiness in older adults could help doctors predict and prevent future medical conditions.”
Feature
COVID-19 cases highlight longstanding racial disparities in health care
Data on higher infection and death rates in African Americans from COVID-19 may serve as a call to action.
From the Journals
Metformin use linked to improved surgery outcomes
“Metformin now joins beta-blockers, statins, and immunonutrition as preoperative agents associated with improved surgical outcomes.”
From the Journals
Inflammatory markers may explain COVID-19, diabetes dynamic
Higher levels of markers may signal greater susceptibility to cytokine storm.
Conference Coverage
Drone flight launches first-ever insulin drop
Collaborators navigated legal and logistic hurdles for the 43-km round trip, a year in the making.
Conference Coverage
Use of diabetes technology is lower among black, Hispanic patients
Researchers are trying to identify specific patient and physician factors that might explain the differences so that they can be addressed.
From the Journals
AHA updates management when CAD and T2DM coincide
Conference Coverage
Loss of tear glands linked to suboptimal diabetes control
Loss of the glands could serve as a diabetes biomarker, particularly in underserved areas where A1c testing might not be readily available.
Conference Coverage
Enhanced team-based CVD care found to benefit diabetes patients
PHOENIX, ARIZ. – “This implementation strategy could be scaled up within primary care settings in China and other low to middle income countries...